logo
Share SHARE
FONT-SIZE Plus   Neg

Oaktree Prices IPO Of 8.84 Million Class A Unit At $43, At Bottom End Of Range

Oaktree Capital Group, LLC global investment management firm focused on alternative markets, announced the pricing of its initial public offering of 8.84 million shares at $43.00 per Class A unit, the bottom of the proposed range.

Of the Class A units to be sold in the offering, Oaktree is offering 7.89 million Class A units and the selling unitholders are offering 954 thousand Class A units.

In an amended regulatory filing with the U.S. Securities and Exchange Commission, the company had expected to offer 11.25 million units at $43 to $46 per share.

Oaktree's Class A units will begin trading on the New York Stock Exchange under the symbol "OAK" on April 12, 2012.

In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1.18 million Class A units from Oaktree and 143 thousand Class A units from the selling unitholders.

The Los Angeles-based asset manager said it will not retain any of the proceeds from the sale of Class A units by the selling unitholders and will use its offering proceeds to acquire interests in the company's business from Oaktree's principals, employees and other investors.

Goldman, Sachs & Co. and Morgan Stanley are acting as joint global coordinators and BofA Merrill Lynch, Credit Suisse, Deutsche Bank Securities and J.P. Morgan are acting as joint bookrunners for this offering.

Oaktree had $74.9 billion in assets under management as of Dec. 31, down from $82.7 billion a year earlier.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Goldman Sachs downgraded the rating of retailer Target Corp. Thursday to sell from neutral over concerns about its increasing competition with e-commerce giant Amazon.com Inc. Target's price target was reduced to $67 from $77. It is expected that the retailer's efforts to compete with Amazon will result in sluggish sales and profits. Catabasis' phase II trial of Edasalonexent in boys affected by Duchenne muscular dystrophy is ongoing, and top-line results are anticipated in the first half of Q1 2017. American Express Co. (AXP) Thursday reported a drop in fourth-quarter profit, as revenues declined 4 percent due to absence of Costco portfolio while provisions for bad loans and marketing costs increased. Earnings fell short of Wall Street estimates, while revenues trumped expectations. New York-based...
comments powered by Disqus
Follow RTT